|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
11,319,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.425 - $0.425 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BG Medicine is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. Co.'s BGM Galectin-3® Test is an in vitro diagnostic device that quantitatively measures galectin-3 levels in blood plasma or serum for use as an aid in assessing the prognosis of chronic heart failure. The BGM Galectin-3® Test is cleared by the U.S. FDA, is CE-marked and is available in the U.S. and the European Union. Co.'s CardioSCORE™ Test is a multi-analyte biomarker-based blood test that is designed as an aid in the assessment of near-term risk for atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Seawell Haygood Paterson Sr |
|
– – – |
2016-05-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,000 |
|
- |
|
| Seawell Haygood Paterson Sr |
|
– – – |
2016-05-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,288,965 |
|
- |
|
| Sohmer Paul R |
President & CEO |
• • – |
2016-03-31 |
4 |
D |
$0.36 |
$5,577 |
D/D |
(15,493) |
53,161 |
|
- |
|
| Hall Stephen P |
EVP & Chief Financial Officer |
• – – |
2016-03-31 |
4 |
D |
$0.36 |
$3,235 |
D/D |
(8,986) |
31,034 |
|
- |
|
| Adourian Aram S. |
SVP & Chief Scientific Officer |
• – – |
2016-03-31 |
4 |
D |
$0.36 |
$2,684 |
D/D |
(7,456) |
35,770 |
|
- |
|
| Afeyan Noubar |
Director |
– • • |
2015-12-09 |
4 |
S |
$0.56 |
$1,404 |
I/I |
(2,508) |
0 |
|
- |
|
| Afeyan Noubar |
Director |
– • • |
2015-12-09 |
4 |
S |
$0.56 |
$24,601 |
D/D |
(43,930) |
0 |
|
- |
|
| Adourian Aram S. |
SVP & Chief Scientific Officer |
• – – |
2015-08-15 |
4/A |
D |
$0.83 |
$5,173 |
D/D |
(6,233) |
43,226 |
|
- |
|
| Hall Stephen P |
EVP & Chief Financial Officer |
• – – |
2015-08-15 |
4/A |
D |
$0.83 |
$6,250 |
D/D |
(7,530) |
40,020 |
|
- |
|
| Adourian Aram S. |
SVP & Chief Scientific Officer |
• – – |
2015-08-15 |
4 |
D |
$0.83 |
$5,173 |
D/D |
(6,233) |
40,226 |
|
- |
|
| Hall Stephen P |
EVP & Chief Financial Officer |
• – – |
2015-08-15 |
4 |
D |
$0.83 |
$6,229 |
D/D |
(7,505) |
39,995 |
|
- |
|
| Sohmer Paul R |
President & CEO |
• • – |
2015-08-15 |
4 |
D |
$0.83 |
$11,056 |
D/D |
(13,321) |
68,654 |
|
- |
|
| Agtc Partners, L.p. |
10% Owner |
– – • |
2015-07-27 |
4 |
S |
$2.27 |
$686 |
I/I |
(302) |
58,232 |
|
- |
|
| Agtc Partners, L.p. |
10% Owner |
– – • |
2015-07-27 |
4 |
OE |
$0.14 |
$669 |
I/I |
4,780 |
58,264 |
|
- |
|
| Agtc Partners, L.p. |
10% Owner |
– – • |
2015-07-27 |
4 |
S |
$2.27 |
$11,305 |
I/I |
(4,980) |
786,970 |
|
- |
|
| Agtc Partners, L.p. |
10% Owner |
– – • |
2015-07-27 |
4 |
OE |
$0.14 |
$11,072 |
I/I |
79,087 |
787,500 |
|
- |
|
| Flagship Ventures Fund 2007, L.p. |
10% Owner |
– – • |
2015-07-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
441,071 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2014-12-11 |
4 |
S |
$0.30 |
$116,274 |
I/I |
(387,580) |
0 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2014-12-10 |
4 |
S |
$0.32 |
$36,710 |
I/I |
(114,720) |
369,112 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2014-12-09 |
4 |
S |
$0.36 |
$47,552 |
I/I |
(132,090) |
478,360 |
|
- |
|
| Kania Edwin M Jr |
10% Owner |
– – • |
2014-12-04 |
4 |
A |
$0.00 |
$0 |
I/I |
634,390 |
604,149 |
|
- |
|
| Newcogen Group, Inc. |
10% Owner |
– – • |
2014-12-04 |
4 |
A |
$0.00 |
$0 |
I/I |
10,029 |
10,029 |
|
- |
|
| Newcogen Group, Inc. |
10% Owner |
– – • |
2014-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
164,528 |
175,718 |
|
- |
|
| Newcogen Group, Inc. |
10% Owner |
– – • |
2014-12-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,484,192) |
0 |
|
- |
|
| Newcogen Group, Inc. |
10% Owner |
– – • |
2014-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
11,190 |
0 |
|
- |
|
38 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
